Status:
COMPLETED
Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity
Lead Sponsor:
Crystal A. Gadegbeku
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Blood Pressure
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
This is a research project to test two study techniques among healthy adults. The procedures look at how blood flow is controlled by substances in blood vessels.
Detailed Description
Most patients with chronic kidney disease (CKD) have high blood pressure and are at high risk for cardiovascular disease. High blood pressure can be partly caused by narrowing of blood vessels from hi...
Eligibility Criteria
Inclusion
- Healthy men and women:
- Age 18 to 55 years
- Who have Blood Pressure less than or equal to 120/80.
Exclusion
- Individuals with:
- Diabetes, lung disease
- Stomach disease, liver disease
- Blood vessel disease
- Kidney disease
- High blood pressure
- Heart disease
- Hereditary blood disorders
- Hematocrit (amount of red blood cells) less than 30%,
- Who smoke
- Women who are pregnant or lactating
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00240058
Start Date
July 1 2005
End Date
June 1 2006
Last Update
June 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Hospital
Ann Arbor, Michigan, United States, 48109